Skip to content

Research on the Application Value of Continuous Glucose Monitoring System (CGMS) in the Diagnosis and Treatment of Neonatal Hypoglycemia

Research on the Application Value of Continuous Glucose Monitoring System (CGMS) in the Diagnosis and Treatment of Neonatal Hypoglycemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107579
Enrollment
Unknown
Registered
2025-08-14
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal hypoglycemia

Interventions

conventional blood glucose monitoring group:None

Sponsors

Quanzhou First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Newborns with high risk factors for hypoglycemia who undergo blood glucose monitoring within 2 hours of birth; 2. Newborns with no feeding contraindications; 3.Newborns whose families have signed informed consent forms prior to the commencement of the study.

Exclusion criteria

Exclusion criteria: 1. There are severe congenital deformities, metabolic disorders, or serious organic diseases; 2.The patient died during hospitalization, opted out of treatment, or voluntarily left the hospital; 3. The clinical data is incomplete; 4. The patient's family did not sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
the detection rate of hypoglycemia;The time when hypoglycemia was first detected;the duration of hypoglycemia;the severity of hypoglycemia;the amount of time needed to stabilize blood sugar;Glucose infusion volume;Feeding method and feeding amount;

Countries

China

Contacts

Public ContactGuimei Zhong

Quanzhou First Hospital

498207785@qq.com+86 18750595697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026